Long-term efficacy of tenofovir alafenamide in HBeAg-positive and -negative chronic hepatitis B patients treated for up to 8 years in 2 phase 3 studies

JOURNAL OF HEPATOLOGY(2023)

引用 0|浏览25
暂无评分
关键词
tenofovir alafenamide,long-term,hbeag-positive
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要